Jeffrey Paley, Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 25,000 shares at $5.48 ($133K) on 2018-12-03, disclosed to the SEC on 2018-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.48 | 10,000 | $55K | 41.1% |
| 2 | $5.48 | 10,000 | $55K | 41.1% |
| 3 | $4.76 | 5,000 | $24K | 17.8% |
| Total | $5.34 avg | 25,000 | $133K | 100% |
| Filing → |
| DERM | BUY | 2023-10-10 | $45K | — | Filing → |
| DERM | BUY | 2023-09-25 | $89K | — | Filing → |
| RTRX | SELL | 2014-08-18 | $246K | — | Filing → |